Hantaviruses are zoonotic viruses that cause life-threatening diseases when transmitted to humans. Severe hantavirus infection is manifested by impairment of renal function, pulmonary oedema and capillary leakage. Both innate and adaptive immune responses contribute to the pathogenesis, but the underlying mechanisms are not fully understood. Here, we showed that galectin-3-binding protein (Gal-3BP) was upregulated as a result of hantavirus infection both in vitro and in vivo. Gal-3BP is a secreted glycoprotein found in human serum, and increased Gal-3BP levels have been reported in chronic viral infections and in several types of cancer. Our in vitro experiments showed that, whilst Vero E6 cells (an African green monkey kidney cell line) constitutively expressed and secreted Gal-3BP, this protein was detected in primary human cells only as a result of hantavirus infection. Analysis of Gal-3BP levels in serum samples of cynomolgus macaques infected experimentally with hantavirus indicated that hantavirus infection induced Gal-3BP also in vivo. Finally, analysis of plasma samples collected from patients hospitalized because of acute hantavirus infection showed higher Gal-3BP levels during the acute than the convalescent phase. Furthermore, the Gal-3BP levels in patients with haemorrhagic fever with renal syndrome correlated with increased complement activation and with clinical variables reflecting the severity of acute hantavirus infection.
BjörkströmN. K., LindgrenT., StoltzM., FauriatC., BraunM., EvanderM., MichaëlssonJ., MalmbergK. J., KlingströmJ.other authors2011; Rapid expansion and long-term persistence of elevated NK cell numbers in humans infected with hantavirus. J Exp Med 208:13–21 [View Article][PubMed]
DarcissacE. C., VidalV., De La TribonniereX., MoutonY., BahrG. M.2001; Variations in serum IL-7 and 90K/Mac-2 binding protein (Mac-2 BP) levels analysed in cohorts of HIV-1 patients and correlated with clinical changes following antiretroviral therapy. Clin Exp Immunol 126:287–294 [View Article][PubMed]
IiM., YamamotoH., AdachiY., MaruyamaY., ShinomuraY.2006; Role of matrix metalloproteinase-7 (matrilysin) in human cancer invasion, apoptosis, growth, and angiogenesis. Exp Biol Med (Maywood) 231:20–27[PubMed]
JonssonC. B., FigueiredoL. T., VapalahtiO.2010; A global perspective on hantavirus ecology, epidemiology, and disease. Clin Microbiol Rev 23:412–441 [View Article][PubMed]
KittlE. M., HofmannJ., HartmannG., SebestaC., BeerF., BauerK., HuberK. R.2000; Serum protein 90K/Mac-2BP is an independent predictor of disease severity during hepatitis C virus infection. Clin Chem Lab Med 38:205–208 [View Article][PubMed]
KlempaB., MeiselH., RäthS., BartelJ., UlrichR., KrügerD. H.2003; Occurrence of renal and pulmonary syndrome in a region of northeast Germany where Tula hantavirus circulates. J Clin Microbiol 41:4894–4897 [View Article][PubMed]
LafertéS., LohL. C., KeelerV.2000; Monoclonal antibodies specific for human tumor-associated antigen 90K/Mac-2 binding protein: tools to examine protein conformation and function. J Cell Biochem 77:540–559 [View Article][PubMed]
LivakK. J., SchmittgenT. D.2001; Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔT method. Methods 25:402–408 [View Article][PubMed]
MäkeläS., MustonenJ., Ala-HouhalaI., HurmeM., PartanenJ., VapalahtiO., VaheriA., PasternackA.2002; Human leukocyte antigen-B8-DR3 is a more important risk factor for severe Puumala hantavirus infection than the tumor necrosis factor-α(−308) G/A polymorphism. J Infect Dis 186:843–846 [View Article][PubMed]
MustonenJ., PartanenJ., KanervaM., PietiläK., VapalahtiO., PasternackA., VaheriA.1996; Genetic susceptibility to severe course of nephropathia epidemica caused by Puumala hantavirus. Kidney Int 49:217–221 [View Article][PubMed]
NatoliC., OrtonaL., TamburriniE., TinariN., Di StefanoP., D’EgidioM., GhinelliF., SighinolfiL., D’OstilioN.other authors1994; Elevated serum levels of a 90,000 daltons tumor-associated antigen in cancer and in infection by human immunodeficiency virus (HIV). Anticancer Res 14:3B1457–1460[PubMed]
OutinenT. K., MäkeläS. M., Ala-HouhalaI. O., HuhtalaH. S., HurmeM., PaakkalaA. S., PörstiI. H., SyrjänenJ. T., MustonenJ. T.2010; The severity of Puumala hantavirus induced nephropathia epidemica can be better evaluated using plasma interleukin-6 than C-reactive protein determinations. BMC Infect Dis 10:132 [View Article][PubMed]
Shrivastava-RanjanP., RollinP. E., SpiropoulouC. F.2010; Andes virus disrupts the endothelial cell barrier by induction of vascular endothelial growth factor and downregulation of VE-cadherin. J Virol 84:11227–11234 [View Article][PubMed]
ThrailkillK. M., Clay BunnR., FowlkesJ. L.2009; Matrix metalloproteinases: their potential role in the pathogenesis of diabetic nephropathy. Endocrine 35:1–10 [View Article][PubMed]
TuuminenT., KekäläinenE., MäkeläS., Ala-HouhalaI., EnnisF. A., HedmanK., MustonenJ., VaheriA., ArstilaT. P.2007; Human CD8+ T cell memory generation in Puumala hantavirus infection occurs after the acute phase and is associated with boosting of EBV-specific CD8+ memory T cells. J Immunol 179:1988–1995 [View Article][PubMed]
UlmerT. A., KeelerV., AndréS., GabiusH. J., LohL., LafertéS.2010; The tumor-associated antigen 90K/Mac-2-binding protein secreted by human colon carcinoma cells enhances extracellular levels of promatrilysin and is a novel substrate of matrix metalloproteinases-2, -7 (matrilysin) and -9: implications of proteolytic cleavage. Biochim Biophys Acta 1800:336–343 [View Article][PubMed]
VaheriA., MillsJ. N., SpiropoulouC. F., HjelleB.2011; Hantaviruses. In Zoonoses: Biology, Clinical Practice and Public Health, 2nd edn. pp. 307–322 Edited by PalmerS. R., SoulsbyL., BrownD., TorgesonP. Oxford: Oxford University Press;
VapalahtiO., Kallio-KokkoH., SalonenE. M., Brummer-KorvenkontioM., VaheriA.1992; Cloning and sequencing of Puumala virus Sotkamo strain S and M RNA segments: evidence for strain variation in hantaviruses and expression of the nucleocapsid protein. J Gen Virol 73:829–838 [View Article][PubMed]